Evaluating the distribution and clustering of SARS-CoV-2 antibodies in dogs across the United States of America
- PMID: 40593062
- PMCID: PMC12217640
- DOI: 10.1038/s41598-025-06730-2
Evaluating the distribution and clustering of SARS-CoV-2 antibodies in dogs across the United States of America
Abstract
SARS-CoV-2 has been detected in various animal species, including dogs. While human-to-animal transmission has been documented, the extent and distribution of SARS-CoV-2 exposure in dogs across the United States of America (USA) remain unclear. To address this need, we investigated the seroprevalence of SARS-CoV-2 antibodies in dogs in the USA and scanned for spatial and temporal clusters of high seroprevalence. Serum samples from 953 dogs from 37 states were screened by serological assays, and 58 (6.09%) samples tested positive for SARS-CoV-2 antibodies. The lowest seropositivity was detected in the third quarter of 2021 (1.16%), while the highest was in the third and fourth quarters of 2024 (23.26%). Maps visualized the distribution of seroprevalence, and the Pacific Northwest and Florida had high seroprevalence, while the Northeast and Midwest USA had low seroprevalence. Two significant space-time clusters were identified. The primary cluster in areas in the state of Washington in October 2024, and the secondary cluster in Florida in March 2022. These findings highlight the importance of surveillance to understand SARS-CoV-2 epidemiology in companion animals and its implications for public health.
Keywords: Clustering; Dogs; SARS-CoV-2; Seroepidemiologic studies.
© 2025. The Author(s).
Conflict of interest statement
Competing interest: The authors declare no competing interests.
Figures







Similar articles
-
Evidence of SARS-CoV-2 Exposure in Cats and Dogs From Households in Romania and Long-Term Specific Seroconversion in Cats.Vet Med Sci. 2025 May;11(3):e70358. doi: 10.1002/vms3.70358. Vet Med Sci. 2025. PMID: 40294118 Free PMC article.
-
Antibody tests for identification of current and past infection with SARS-CoV-2.Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2. Cochrane Database Syst Rev. 2022. PMID: 36394900 Free PMC article.
-
Detection of SARS-CoV-2- specific antibodies in domestic cats using different ELISA tests.J Virol Methods. 2025 Apr;333:115099. doi: 10.1016/j.jviromet.2024.115099. Epub 2024 Dec 9. J Virol Methods. 2025. PMID: 39662743
-
Ultrafast and high-throughput immunoassay assay to detect anti-SARS-CoV-2 IgG antibodies in dogs and cats.Braz J Microbiol. 2024 Dec;55(4):4183-4189. doi: 10.1007/s42770-024-01518-4. Epub 2024 Sep 20. Braz J Microbiol. 2024. PMID: 39302629
-
Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020 to August 2021: a systematic review and meta-analysis.Int J Infect Dis. 2022 Mar;116:59-67. doi: 10.1016/j.ijid.2021.12.353. Epub 2021 Dec 28. Int J Infect Dis. 2022. PMID: 34968773 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous